BVS Bioventus Inc Total Asset Value of Company

Official company branding of Bioventus Inc (BVS)

Bioventus Inc. (BVS) specializes in the development of orthopedic products while actively implementing ESG principles by minimizing production waste and utilizing energy-saving technologies. The business is steadily regaining investor confidence following a restructuring of its debt obligations, leveraging its impeccable brand image. The market trend for the asset shown on this price chart reflects total aggregate assets at 690.24, supported by stable demand for bone regeneration systems.

Company Total Assets: Bioventus (BVS) for 07/04/2022 - 10/30/2026

Financial and market metric breakdowns for Bioventus Corp (BVS)

- current quotes and average value forecast:
Market Chart bioventus.com|BVS - Price Target Chart
- market capitalization data:
Market Valuation Bioventus Global|BVS - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Bioventus|BVS - Book Capitalization|Market Cap to Net Assets Ratio bioventus.com|BVS - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Bioventus Inc.|BVS - Long-Term Debt to Capital|Short-Term Debt to Capital Bioventus Global|BVS - Company Debts|Debt to Book Capitalization Ratio Bioventus Global|BVS - Company Long-Term Debts|Short-Term Debt Volume Bioventus|Critical Liquidity Ratio bioventus.com
- company profitability and valuation multiples indicators:
BVS - Net Profit
Basic company analysis:bioventus.com, BVS
Mass-produced product of Bioventus Corp

Steady demand for Bioventus Inc. (BVS) rehabilitation systems and innovative surgery ensures sustainable growth in production capacity. This metric, calculated inversely via ROA, measures the company's total resource volume, allowing investors to assess capital management efficiency and identify business expansion phases by analyzing the history of balance sheet assets to detect signals of undervaluation or overvaluation of the stock.

Direct competitors

BSX - Company Total Asset Base|Aggregate Company Assets Edwards Lifesciences Corporation|ResMed Inc - Total Asset Value of Company|Company Total Assets PODD|ZBH - Company Assets|Company Total Assets COO (The Cooper Companies)|ALGN - Cumulative Company Assets|Globus Medical - Company Total Assets|Company Total Asset Base transmedics.com TMDX|ATEC: Company Total Assets|Artivion Corp (AORT) - Company Total Assets|Aggregate Company Assets Enovis Corporation|Aggregate Company Assets IART|Company Total Assets ESTA|Company Total Asset Base Beta Bionics, Inc.|Iradimed - Cumulative Company Assets|EMBC (Embecta Health) - Total Asset Value of Company|Tandem Diabetes Care - Company Total Assets|Company Assets axogeninc.com|SIBN: Company Total Assets|Total Business Assets OFIX|Cumulative Company Assets KIDS|TMCI: Aggregate Asset Value|Aggregate Company Assets Strata Critical Medical Inc (SRTA)|Cumulative Company Assets carlsmed.com CARL|Company Total Assets RXST (RxSight)|ClearPoint Neuro Inc. (CLPT) - Company Assets|Stereotaxis Corp - Company Total Assets|STIM (Neuronetics, Inc) - Total Business Assets|SGHT: Company Total Assets|OBIO - Company Total Asset Base|ANIK (Anika Therapeutics Inc.) - Company Total Assets|Cumulative Company Assets InspireMD Inc (NSPR)|Company Total Assets ZJYL|Company Total Assets vivani.com (VANI)|Aggregate Company Assets Xtant Medical XTNT|n1mtc.com - Aggregate Company Assets|MODD: Cumulative Company Assets|Aggregate Asset Value MYO (Myomo Inc.)|COCH: Company Total Assets|Company Assets Vivos Therapeutics Inc (VVOS)|Aggregate Company Assets enVVeno Medical|SINT - Company Balance Sheet Assets|Cumulative Company Assets TNON (Tenon Medical)|Company Total Assets ReWalk Robotics (LFWD)|Company Total Assets AMIX (Autonomix Medical)|Company Total Asset Base INVO Fertility Corp (IVF)|BBLG - Aggregate Company Assets|Total Asset Value of Company AXNX|BIOLASE (BIOL) - Aggregate Company Assets|Cumulative Company Assets Dynatronics|FNA (Paragon 28 Inc.) - Company Total Assets|Company Assets INVO Bio INVO